Table 2. Tumour response rates based on RECIST guidelines.
| |
Best response with ridaforolimus,
n
(N=45) |
||
|---|---|---|---|
| Tumour histology | CR | PR | SDa |
| Endometrioid (n=28) |
0 |
3 |
7 |
| Papillary serous (n=10) |
0 |
1 |
1 |
| Mixed epithelial (n=1) |
0 |
1 |
0 |
| Carcinosarcoma or MMMT (n=5) |
0 |
0 |
0 |
| Total, n (%) | 0 | 5 (11) | 8 (18) |
Abbreviations: CR=complete response; MMMT=malignant mixed Müllerian tumour; PR=partial response; RECIST=Response Evaluation Criteria in Solid Tumours; SD=stable disease.
a
SD for a duration of at least 16 weeks.